HIGHLIGHTS
- who: Chen Zhang and collaborators from the The Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University School of Medicine, Changsha, China have published the paper: Sorafenib/2800Z Co-Loaded into Cholesterol and PEG Grafted Polylysine NPs for Liver Cancer Treatment, in the Journal: Pharmaceuticals 2023, 119 of /2023/
SUMMARY
Ph16010119 During recent decades, great efforts have been made to improve the treatment of liver cancer. Liver cancer therapy remains challenging due to the low responsiveness of advanced cancer to therapeutic options. Sorafenib (SOR) is the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.